Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients.

Hammer F, Malzahn U, Donhauser J, Betz C, Schneider MP, Grupp C, Pollak N, Störk S, Wanner C, Krane V; MiREnDa Study Group.

Kidney Int. 2019 Apr;95(4):983-991. doi: 10.1016/j.kint.2018.11.025. Epub 2019 Jan 31.

PMID:
30712923
2.

Drugs linked to plasma homoarginine in chronic kidney disease patients-a cross-sectional analysis of the German Chronic Kidney Disease cohort.

Maas R, Mieth M, Titze SI, Hübner S, Fromm MF, Kielstein JT, Schmid M, Köttgen A, Kronenberg F, Krane V, Hausknecht B, Eckardt KU, Schneider MP; GCKD study investigators .

Nephrol Dial Transplant. 2018 Nov 23. doi: 10.1093/ndt/gfy342. [Epub ahead of print]

PMID:
30476224
3.

Cardiovascular Outcomes Reported in Hemodialysis Trials.

O'Lone E, Viecelli AK, Craig JC, Tong A, Sautenet B, Roy D, Herrington WG, Herzog CA, Jafar T, Jardine M, Krane V, Levin A, Malyszko J, Rocco MV, Strippoli G, Tonelli M, Wang AYM, Wanner C, Zannad F, Winkelmayer WC, Webster AC, Wheeler DC.

J Am Coll Cardiol. 2018 Jun 19;71(24):2802-2810. doi: 10.1016/j.jacc.2018.04.012. Review.

PMID:
29903353
4.

Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 Diabetes.

Triebswetter S, Gutjahr-Lengsfeld LJ, Schmidt KR, Drechsler C, Wanner C, Krane V.

Am J Nephrol. 2018;47(1):30-39. doi: 10.1159/000485842. Epub 2018 Jan 10.

PMID:
29320770
5.

Prognostic Value of High-Sensitivity Versus Conventional Cardiac Troponin T Assays Among Patients With Type 2 Diabetes Mellitus Undergoing Maintenance Hemodialysis.

Keller T, Wanner C, Krane V, Kraus D, Genser B, Scharnagl H, März W, Drechsler C.

Am J Kidney Dis. 2018 Jun;71(6):822-830. doi: 10.1053/j.ajkd.2017.10.016. Epub 2018 Jan 6.

PMID:
29310884
6.

Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.

Drechsler C, Hayek SS, Wei C, Sever S, Genser B, Krane V, Meinitzer A, März W, Wanner C, Reiser J.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1265-1273. doi: 10.2215/CJN.10881016. Epub 2017 May 11.

7.

Copeptin Associates with Cause-Specific Mortality in Patients with Impaired Renal Function: Results from the LURIC and the 4D Study.

Krane V, Genser B, Kleber ME, Drechsler C, März W, Delgado G, Allolio B, Wanner C, Fenske W; 4D and LURIC study investigators.

Clin Chem. 2017 May;63(5):997-1007. doi: 10.1373/clinchem.2016.266254. Epub 2017 Mar 9.

8.

Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.

Kollerits B, Drechsler C, Krane V, Lamina C, März W, Dieplinger H, Ritz E, Wanner C, Kronenberg F; German Diabetes and Dialysis Study Investigators.

Nephrol Dial Transplant. 2016 Nov;31(11):1901-1908. Epub 2016 Jan 10.

PMID:
26754832
9.

They need to be recognized as a person in everyday life: Teachers' and helpers' experiences of teacher-student relationships in upper secondary school.

Krane V, Karlsson B, Ness O, Binder PE.

Int J Qual Stud Health Well-being. 2016 Oct 4;11:31634. doi: 10.3402/qhw.v11.31634. eCollection 2016.

10.

HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients.

Kopecky C, Ebtehaj S, Genser B, Drechsler C, Krane V, Antlanger M, Kovarik JJ, Kaltenecker CC, Parvizi M, Wanner C, Weichhart T, Säemann MD, Tietge UJ.

J Am Soc Nephrol. 2017 Mar;28(3):769-775. doi: 10.1681/ASN.2016030262. Epub 2016 Sep 9.

11.

Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort.

Busch M, Nadal J, Schmid M, Paul K, Titze S, Hübner S, Köttgen A, Schultheiss UT, Baid-Agrawal S, Lorenzen J, Schlieper G, Sommerer C, Krane V, Hilge R, Kielstein JT, Kronenberg F, Wanner C, Eckardt KU, Wolf G; GCKD Study Investigators.

BMC Nephrol. 2016 Jun 11;17(1):59. doi: 10.1186/s12882-016-0273-z.

12.

Should we aim for oral health to improve outcomes in chronic kidney disease?

Krane V, Wanner C.

Nephrol Dial Transplant. 2016 Oct;31(10):1551-4. doi: 10.1093/ndt/gfw049. Epub 2016 May 13. No abstract available.

PMID:
27190378
13.

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP).

Staplin N, Haynes R, Herrington WG, Reith C, Cass A, Fellström B, Jiang L, Kasiske BL, Krane V, Levin A, Walker R, Wanner C, Wheeler DC, Landray MJ, Baigent C, Emberson J; SHARP Collaborative Group.

Am J Kidney Dis. 2016 Sep;68(3):371-80. doi: 10.1053/j.ajkd.2016.02.052. Epub 2016 Apr 23.

14.

Long-term effects following 4 years of randomized treatment with atorvastatin in patients with type 2 diabetes mellitus on hemodialysis.

Krane V, Schmidt KR, Gutjahr-Lengsfeld LJ, Mann JF, März W, Swoboda F, Wanner C; 4D Study Investigators (the German Diabetes and Dialysis Study Investigators).

Kidney Int. 2016 Jun;89(6):1380-7. doi: 10.1016/j.kint.2015.12.033. Epub 2016 Feb 17.

PMID:
26924051
15.

Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates.

Schneider MP, Hübner S, Titze SI, Schmid M, Nadal J, Schlieper G, Busch M, Baid-Agrawal S, Krane V, Wanner C, Kronenberg F, Eckardt KU.

Kidney Int. 2015 Dec;88(6):1411-1418. doi: 10.1038/ki.2015.246. Epub 2015 Sep 2.

PMID:
26331409
16.

Correction: Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study.

Beck H, Titze SI, Hübner S, Busch M, Schlieper G, Schultheiss UT, Wanner C, Kronenberg F, Krane V, Eckardt KU, Köttgen A; GCKD Investigators.

PLoS One. 2015 Jun 15;10(6):e0131034. doi: 10.1371/journal.pone.0131034. eCollection 2015. No abstract available.

17.

Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients.

Silbernagel G, Fauler G, Genser B, Drechsler C, Krane V, Scharnagl H, Grammer TB, Baumgartner I, Ritz E, Wanner C, März W.

J Am Coll Cardiol. 2015 Jun 2;65(21):2291-8. doi: 10.1016/j.jacc.2015.03.551.

18.

Heart failure in a cohort of patients with chronic kidney disease: the GCKD study.

Beck H, Titze SI, Hübner S, Busch M, Schlieper G, Schultheiss UT, Wanner C, Kronenberg F, Krane V, Eckardt KU, Köttgen A; GCKD Investigators.

PLoS One. 2015 Apr 13;10(4):e0122552. doi: 10.1371/journal.pone.0122552. eCollection 2015. Erratum in: PLoS One. 2015;10(6):e0131034.

19.

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies.

Drechsler C, Delgado G, Wanner C, Blouin K, Pilz S, Tomaschitz A, Kleber ME, Dressel A, Willmes C, Krane V, Krämer BK, März W, Ritz E, van Gilst WH, van der Harst P, de Boer RA.

J Am Soc Nephrol. 2015 Sep;26(9):2213-21. doi: 10.1681/ASN.2014010093. Epub 2015 Jan 7.

20.

Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.

Kopecky C, Genser B, Drechsler C, Krane V, Kaltenecker CC, Hengstschläger M, März W, Wanner C, Säemann MD, Weichhart T.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):224-31. doi: 10.2215/CJN.06560714. Epub 2014 Nov 25.

21.

Pregnancy-associated plasma protein A associates with cardiovascular events in diabetic hemodialysis patients.

Kalousová M, Zima T, Krane V, März W, Wanner C, Tesař V, Drechsler C; German Diabetes and Dialysis Study Investigators.

Atherosclerosis. 2014 Oct;236(2):263-9. doi: 10.1016/j.atherosclerosis.2014.07.003. Epub 2014 Jul 12.

22.

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

Silbernagel G, Genser B, Drechsler C, Scharnagl H, Grammer TB, Stojakovic T, Krane V, Ritz E, Wanner C, März W.

J Am Soc Nephrol. 2015 Feb;26(2):484-92. doi: 10.1681/ASN.2013080816. Epub 2014 Jul 10.

23.

Homoarginine, kidney function and cardiovascular mortality risk.

Tomaschitz A, Meinitzer A, Pilz S, Rus-Machan J, Genser B, Drechsler C, Grammer T, Krane V, Ritz E, Kleber ME, Pieske B, Kraigher-Krainer E, Fahrleitner-Pammer A, Wanner C, Boehm BO, März W.

Nephrol Dial Transplant. 2014 Mar;29(3):663-71. doi: 10.1093/ndt/gft512. Epub 2014 Jan 6.

PMID:
24398889
24.

Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.

Drechsler C, Schneider A, Gutjahr-Lengsfeld L, Kroiss M, Carrero JJ, Krane V, Allolio B, Wanner C, Fassnacht M.

Am J Kidney Dis. 2014 Jun;63(6):988-96. doi: 10.1053/j.ajkd.2013.10.009. Epub 2013 Dec 4.

PMID:
24315768
25.

Rationale and design of the Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Study (MiREnDa).

Hammer F, Krane V, Störk S, Röser C, Hofmann K, Pollak N, Allolio B, Wanner C.

Nephrol Dial Transplant. 2014 Feb;29(2):400-5. doi: 10.1093/ndt/gft409. Epub 2013 Oct 28.

PMID:
24166468
26.

Results of the 4D study: ten years of follow-up?

Wanner C, Schmidt KR, Krane V.

Clin Exp Nephrol. 2014 Apr;18(2):274-7. doi: 10.1007/s10157-013-0888-3. Epub 2013 Oct 29. Review.

PMID:
24165684
27.

Genome-wide association study identifies 3 genomic loci significantly associated with serum levels of homoarginine: the AtheroRemo Consortium.

Kleber ME, Seppälä I, Pilz S, Hoffmann MM, Tomaschitz A, Oksala N, Raitoharju E, Lyytikäinen LP, Mäkelä KM, Laaksonen R, Kähönen M, Raitakari OT, Huang J, Kienreich K, Fahrleitner-Pammer A, Drechsler C, Krane V, Boehm BO, Koenig W, Wanner C, Lehtimäki T, März W, Meinitzer A.

Circ Cardiovasc Genet. 2013 Oct;6(5):505-13. doi: 10.1161/CIRCGENETICS.113.000108. Epub 2013 Sep 18.

PMID:
24047826
28.

Study design of DIACORE (DIAbetes COhoRtE) - a cohort study of patients with diabetes mellitus type 2.

Dörhöfer L, Lammert A, Krane V, Gorski M, Banas B, Wanner C, Krämer BK, Heid IM, Böger CA; DIACORE Study Group.

BMC Med Genet. 2013 Feb 14;14:25. doi: 10.1186/1471-2350-14-25.

29.

Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients.

Espe KM, Raila J, Henze A, Blouin K, Schneider A, Schmiedeke D, Krane V, Pilz S, Schweigert FJ, Hocher B, Wanner C, Drechsler C; German Diabetes and Dialysis Study Investigators.

Clin J Am Soc Nephrol. 2013 Mar;8(3):452-8. doi: 10.2215/CJN.04880511. Epub 2013 Jan 18.

30.

Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients.

Drechsler C, Ritz E, Tomaschitz A, Pilz S, Schönfeld S, Blouin K, Bidlingmaier M, Hammer F, Krane V, März W, Allolio B, Fassnacht M, Wanner C.

Eur Heart J. 2013 Feb;34(8):578-87. doi: 10.1093/eurheartj/ehs361. Epub 2012 Dec 4.

31.

Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials.

Rahimi K, Bhala N, Kamphuisen P, Emberson J, Biere-Rafi S, Krane V, Robertson M, Wikstrand J, McMurray J.

PLoS Med. 2012;9(9):e1001310. doi: 10.1371/journal.pmed.1001310. Epub 2012 Sep 18.

32.

Transthyretin predicts cardiovascular outcome in hemodialysis patients with type 2 diabetes.

Henze A, Espe KM, Wanner C, Krane V, Raila J, Hocher B, Schweigert FJ, Drechsler C.

Diabetes Care. 2012 Nov;35(11):2365-72. doi: 10.2337/dc12-0455. Epub 2012 Aug 24.

33.

Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus--a post hoc analysis of the 4D Study.

Kollerits B, Krane V, Drechsler C, Lamina C, März W, Ritz E, Wanner C, Kronenberg F; German Diabetes and Dialysis Study Investigators.

J Intern Med. 2012 Dec;272(6):592-600. doi: 10.1111/j.1365-2796.2012.02585.x. Epub 2012 Sep 12.

34.

Resilient excellence: challenges faced by trailblazing women in U.S. sport psychology.

Whaley DE, Krane V.

Res Q Exerc Sport. 2012 Mar;83(1):65-76.

PMID:
22428413
35.

"It's cheesy when they smile:" what girl athletes prefer in images of female college athletes.

Krane V, Ross SR, Miller M, Ganoe K, Lucas-Carr C, Barak KS.

Res Q Exerc Sport. 2011 Dec;82(4):755-68.

PMID:
22276417
36.

Lipoprotein-associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysis.

Winkler K, Hoffmann MM, Krane V, Drechsler C, Wanner C; German Diabetes and Dialysis Study Investigators.

Eur J Clin Invest. 2012 Jul;42(7):693-701. doi: 10.1111/j.1365-2362.2011.02634.x. Epub 2011 Dec 29.

PMID:
22211481
37.

The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS study.

Schneider A, Drechsler C, Krane V, Krieter DH, Scharnagl H, Schneider MP, Wanner C; MINOXIS Study Investigators.

Clin J Am Soc Nephrol. 2012 Jan;7(1):52-9. doi: 10.2215/CJN.02710311. Epub 2011 Nov 17.

38.

Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD.

Böger CA, Gorski M, Li M, Hoffmann MM, Huang C, Yang Q, Teumer A, Krane V, O'Seaghdha CM, Kutalik Z, Wichmann HE, Haak T, Boes E, Coassin S, Coresh J, Kollerits B, Haun M, Paulweber B, Köttgen A, Li G, Shlipak MG, Powe N, Hwang SJ, Dehghan A, Rivadeneira F, Uitterlinden A, Hofman A, Beckmann JS, Krämer BK, Witteman J, Bochud M, Siscovick D, Rettig R, Kronenberg F, Wanner C, Thadhani RI, Heid IM, Fox CS, Kao WH; CKDGen Consortium.

PLoS Genet. 2011 Sep;7(9):e1002292. doi: 10.1371/journal.pgen.1002292. Epub 2011 Sep 29.

39.

The German Chronic Kidney Disease (GCKD) study: design and methods.

Eckardt KU, Bärthlein B, Baid-Agrawal S, Beck A, Busch M, Eitner F, Ekici AB, Floege J, Gefeller O, Haller H, Hilge R, Hilgers KF, Kielstein JT, Krane V, Köttgen A, Kronenberg F, Oefner P, Prokosch HU, Reis A, Schmid M, Schaeffner E, Schultheiss UT, Seuchter SA, Sitter T, Sommerer C, Walz G, Wanner C, Wolf G, Zeier M, Titze S.

Nephrol Dial Transplant. 2012 Apr;27(4):1454-60. doi: 10.1093/ndt/gfr456. Epub 2011 Aug 22.

PMID:
21862458
40.

Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie).

Drechsler C, Grootendorst DC, Pilz S, Tomaschitz A, Krane V, Dekker F, März W, Ritz E, Wanner C.

Am J Kidney Dis. 2011 Oct;58(4):599-607. doi: 10.1053/j.ajkd.2011.05.026. Epub 2011 Aug 5.

PMID:
21820222
41.

Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients.

Drechsler C, Meinitzer A, Pilz S, Krane V, Tomaschitz A, Ritz E, März W, Wanner C.

Eur J Heart Fail. 2011 Aug;13(8):852-9. doi: 10.1093/eurjhf/hfr056.

42.

Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.

Wanner C, Krane V.

Kidney Blood Press Res. 2011;34(4):209-17. doi: 10.1159/000326849. Epub 2011 Jun 21. Review.

43.

Sunrise of statins after AURORA and 4D?

Wanner C, Krane V.

J Am Soc Nephrol. 2011 Jul;22(7):1184-6. doi: 10.1681/ASN.2011050504. Epub 2011 Jun 16. No abstract available.

44.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators.

Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12.

45.

Statins, inflammation and kidney disease.

Krane V, Wanner C.

Nat Rev Nephrol. 2011 May 31;7(7):385-97. doi: 10.1038/nrneph.2011.62. Review.

PMID:
21629228
46.

Low homoarginine concentration is a novel risk factor for heart disease.

Pilz S, Meinitzer A, Tomaschitz A, Drechsler C, Ritz E, Krane V, Wanner C, Boehm BO, März W.

Heart. 2011 Aug;97(15):1222-7. doi: 10.1136/hrt.2010.220731. Epub 2011 May 10.

PMID:
21558479
47.

Impact of vitamin A on clinical outcomes in haemodialysis patients.

Espe KM, Raila J, Henze A, Krane V, Schweigert FJ, Hocher B, Wanner C, Drechsler C; German Diabetes and Dialysis Study Investigators.

Nephrol Dial Transplant. 2011 Dec;26(12):4054-61. doi: 10.1093/ndt/gfr171. Epub 2011 May 4.

PMID:
21543660
48.

Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis.

März W, Genser B, Drechsler C, Krane V, Grammer TB, Ritz E, Stojakovic T, Scharnagl H, Winkler K, Holme I, Holdaas H, Wanner C; German Diabetes and Dialysis Study Investigators.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1316-25. doi: 10.2215/CJN.09121010. Epub 2011 Apr 14.

49.

Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus.

Fenske W, Wanner C, Allolio B, Drechsler C, Blouin K, Lilienthal J, Krane V; German Diabetes, Dialysis Study Investigators.

J Am Soc Nephrol. 2011 Apr;22(4):782-90. doi: 10.1681/ASN.2010070691. Epub 2011 Mar 17.

50.

Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.

Rahimi K, Emberson J, McGale P, Majoni W, Merhi A, Asselbergs FW, Krane V, Macfarlane PW; PROSPER Executive.

BMJ. 2011 Mar 16;342:d1250. doi: 10.1136/bmj.d1250.

PMID:
21411487

Supplemental Content

Support Center